Literature DB >> 6311019

A murine model of asbestosis.

B E Bozelka, P Sestini, H R Gaumer, Y Hammad, C J Heather, J E Salvaggio.   

Abstract

Balb/c mice were exposed to aerosolized chrysotile fibers and evaluated as a host for the study of asbestos-induced pulmonary disease. Histologically, an initial macrophage reaction was found to progress to "asbestos body" formation and diffuse focal interstitial fibrosis within 1 year of a chronic exposure period. This reaction was most intense in areas adjacent to respiratory bronchioles and alveolar ducts. Two morphologically distinct tumors at the pulmonary visceral surface were also discovered among a high percentage of asbestos-exposed mice. Bronchoalveolar lavage demonstrated an eventual alteration of the retrievable cell populations among the dusted animals. Evaluation of systemic B-lymphocyte activity suggested a stimulation of this cell subset following chrysotile inhalation. These results demonstrate that subsequent to chronic asbestos exposure, the mouse develops pulmonary and immunologic changes very similar to those noted in human asbestosis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6311019      PMCID: PMC1916394     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  34 in total

Review 1.  Mineral fibers: chemical, physicochemical, and biological properties.

Authors:  J S Harington; A C Allison; D V Badami
Journal:  Adv Pharmacol Chemother       Date:  1975

2.  Immunological studies of patients with asbestosis. I. Studies of cell-mediated immunity.

Authors:  E Kagan; A Solomon; J C Cochrane; E I Beissner; J Gluckman; P H Rocks; I Webster
Journal:  Clin Exp Immunol       Date:  1977-05       Impact factor: 4.330

3.  Some biochemical effects of asbestos on macrophages.

Authors:  K Miller; J S Harington
Journal:  Br J Exp Pathol       Date:  1972-08

4.  Asbestos-body formation in the lungs of rats and guinea-pigs after inhalation of anthophyllite.

Authors:  S K Botham; P F Holt
Journal:  J Pathol       Date:  1972-08       Impact factor: 7.996

5.  The role of the alveolar macrophage.

Authors:  Q N Myrvik
Journal:  J Occup Med       Date:  1973-03

6.  Mechanisms of mesothelioma induction with asbestos and fibrous glass.

Authors:  M F Stanton; C Wrench
Journal:  J Natl Cancer Inst       Date:  1972-03       Impact factor: 13.506

7.  Antitrinitrophenyl (TNP) plaque assay. Primary response of Balb/c mice to soluble and particulate immunogen.

Authors:  M B Rittenberg; K L Pratt
Journal:  Proc Soc Exp Biol Med       Date:  1969-11

8.  Immunological studies of patients with asbestosis. II, Studies of circulating lymphoid cell numbers and humoral immunity.

Authors:  E Kagan; A Solomon; J C Cochrane; P Kuba; P H Rocks; I Webster
Journal:  Clin Exp Immunol       Date:  1977-05       Impact factor: 4.330

9.  The application of a mathematical model describing the times of occurrence of mesotheliomas in rats following inoculation with asbestos.

Authors:  G Berry; J C Wagner
Journal:  Br J Cancer       Date:  1969-09       Impact factor: 7.640

10.  The effects of the inhalation of asbestos in rats.

Authors:  J C Wagner; G Berry; J W Skidmore; V Timbrell
Journal:  Br J Cancer       Date:  1974-03       Impact factor: 7.640

View more
  12 in total

1.  Immunological consequences of asbestos exposure.

Authors:  D P Hartmann
Journal:  Surv Immunol Res       Date:  1985

2.  Role of p53 in the chronic pulmonary immune response to tangled or rod-like multi-walled carbon nanotubes.

Authors:  Katherine S Duke; Elizabeth A Thompson; Mark D Ihrie; Alexia J Taylor-Just; Elizabeth A Ash; Kelly A Shipkowski; Jonathan R Hall; Debra A Tokarz; Mark F Cesta; Ann F Hubbs; Dale W Porter; Linda M Sargent; James C Bonner
Journal:  Nanotoxicology       Date:  2018-10-14       Impact factor: 5.913

3.  Species-specific immune responses generated by histidyl-tRNA synthetase immunization are associated with muscle and lung inflammation.

Authors:  Yasuhiro Katsumata; William M Ridgway; Timothy Oriss; Xinyan Gu; David Chin; Yuehong Wu; Noreen Fertig; Tim Oury; Daniel Vandersteen; Paula Clemens; Carlos J Camacho; Andrew Weinberg; Dana P Ascherman
Journal:  J Autoimmun       Date:  2007 Sep-Nov       Impact factor: 7.094

4.  Increased manganese superoxide dismutase protein in type II epithelial cells of rat lungs after inhalation of crocidolite asbestos or cristobalite silica.

Authors:  J A Holley; Y M Janssen; B T Mossman; D J Taatjes
Journal:  Am J Pathol       Date:  1992-08       Impact factor: 4.307

5.  Modulation of macrophage suppressive activity and prostaglandin release by lymphokines and interferon: comparison of alveolar, pleural and peritoneal macrophages.

Authors:  P Sestini; A Tagliabue; D Boraschi
Journal:  Clin Exp Immunol       Date:  1984-12       Impact factor: 4.330

Review 6.  The role of inflammation in the pathogenesis of idiopathic pulmonary fibrosis.

Authors:  Benjamin D Bringardner; Christopher P Baran; Timothy D Eubank; Clay B Marsh
Journal:  Antioxid Redox Signal       Date:  2008-02       Impact factor: 8.401

7.  Kinetics of the bronchoalveolar leucocyte response in rats during exposure to equal airborne mass concentrations of quartz, chrysotile asbestos, or titanium dioxide.

Authors:  K Donaldson; R E Bolton; A Jones; G M Brown; M D Robertson; J Slight; H Cowie; J M Davis
Journal:  Thorax       Date:  1988-07       Impact factor: 9.139

Review 8.  Pulmonary carcinogenicity of inhaled particles and the maximum tolerated dose.

Authors:  G Oberdörster
Journal:  Environ Health Perspect       Date:  1997-09       Impact factor: 9.031

Review 9.  Mouse models for mesothelioma drug discovery and development.

Authors:  Kenneth P Seastedt; Nathanael Pruett; Chuong D Hoang
Journal:  Expert Opin Drug Discov       Date:  2020-12-31       Impact factor: 7.050

10.  One-year follow-up of the phagocytic activity of leukocytes after exposure of rats to asbestos and basalt fibers.

Authors:  M Hurbánková
Journal:  Environ Health Perspect       Date:  1994-10       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.